| # | Drug | Count |
|---|---|---|
| 0 | ABACAVIR | 3 |
| 1 | ABACAVIR SULFATE | 3 |
| 2 | LAMIVUDINE | 3 |
| 3 | LAMIVUDINE AND ZIDOVUDINE | 3 |
| 4 | LAMIVUDINE ORAL | 3 |
| 5 | NEVIRAPINE | 3 |
| 6 | VENETOCLAX | 3 |
| 7 | FUROSEMIDE | 2 |
| 8 | RITUXIMAB | 2 |
| 9 | SODIUM CHLORIDE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LAMIVUDINE AND ZIDOVUDINE | 3 | 0.0004 |
| 1 | NEVIRAPINE | 3 | 0.0003 |
| 2 | CALCITONIN SALMON | 1 | 0.0003 |
| 3 | ABACAVIR SULFATE | 3 | 0.0003 |
| 4 | GALSULFASE | 1 | 0.0003 |
| 5 | LAMIVUDINE | 3 | 0.0001 |
| 6 | ZIDOVUDINE | 1 | 0.0001 |
| 7 | STANDARDIZED SENNA CONCENTRATE | 1 | 0.0001 |
| 8 | ACALABRUTINIB | 1 | 0.0001 |
| 9 | OBINUTUZUMAB | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Calcitonin [EPC] | 1 | 0.0003 |
| 1 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0001 |
| 2 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 3 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0001 |
| 4 | BCL-2 Inhibitor [EPC] | 3 | 0.0000 |
| 5 | Iron Chelator [EPC] | 1 | 0.0000 |
| 6 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0000 |
| 7 | beta3-Adrenergic Agonist [EPC] | 1 | 0.0000 |
| 8 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 1 | 0.0000 |
| 9 | Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |